US 12,414,977 B2
Method of administering seaberry and saw palmetto extracts to inhibit 5α-reductase activity
Kenchi Miyasaka, Aichi (JP); Norihito Shimizu, Aichi (JP); Hiroshi Shimoda, Aichi (JP); and Hiromichi Murai, Aichi (JP)
Assigned to ORYZA OIL & FAT CHEMICAL CO., LTD., Aichi (JP)
Appl. No. 17/772,232
Filed by ORYZA OIL & FAT CHEMICAL CO., LTD., Aichi (JP)
PCT Filed May 1, 2020, PCT No. PCT/JP2020/018401
§ 371(c)(1), (2) Date Apr. 27, 2022,
PCT Pub. No. WO2021/145004, PCT Pub. Date Jul. 22, 2021.
Claims priority of application No. 2020-005114 (JP), filed on Jan. 16, 2020.
Prior Publication US 2022/0370539 A1, Nov. 24, 2022
Int. Cl. A61K 36/889 (2006.01); A23L 33/105 (2016.01); A61K 8/9789 (2017.01); A61K 8/9794 (2017.01); A61K 36/185 (2006.01); A61P 13/08 (2006.01); A61P 17/10 (2006.01); A61P 17/14 (2006.01); A61Q 7/00 (2006.01); A61Q 19/00 (2006.01)
CPC A61K 36/889 (2013.01) [A23L 33/105 (2016.08); A61K 8/9789 (2017.08); A61K 8/9794 (2017.08); A61K 36/185 (2013.01); A61P 13/08 (2018.01); A61P 17/10 (2018.01); A61P 17/14 (2018.01); A61Q 7/00 (2013.01); A61Q 19/00 (2013.01)] 3 Claims
 
1. A method for inhibiting 5α-reductase activity in a human body, comprising administering a saw palmetto extract and a seaberry extract to the human body in order to inhibit 5α-reductase activity, wherein a compounding ratio by weight of the saw palmetto extract and seaberry extract is 3:1-2 when administered, the administering using the compounding ratio showing a synergistic effect.